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Abstract: Nowadays, there is an increase in the application of natural products for the prevention 
of different disorders or adjuvant substances next to pharmacological treatment. Phytochemicals 
include different chromone derivatives, which possess a wide spectrum of biological activity.  
The aim of the present study was the investigation of the antioxidant activity, cytotoxicity and 
oxidative transformation of nine chromone derivatives. First, we investigated the radical scavenging 
activity (ABTS), the oxygen radical absorption capacity (ORAC) and the ferric reducing antioxidant 
power (FRAP) of the investigated molecules. The cytotoxic effects of the compounds were tested on 
H9c2 cell cultures by the MTT assay. Each compound showed a significant ORAC value compared 
to the reference. However, the compound 865 possess significantly higher FRAP and ABTS activity 
in comparison with the reference and other tested molecules, respectively. Based on these assays, 
the compound 865 was selected for further analysis. In these experiments, we investigated the 
oxidative metabolism of the compound in vitro. The molecule was oxidized by the Fenton reaction, 
artificial porphyrin and electrochemistry; then, the formed products were identified by mass 
spectrometry. Four possible metabolites were detected. The results revealed the compound 865 to 
possess good antioxidant properties and to be stable metabolically; hence, it is worth investigating 
its effects in vivo. 
Keywords: antioxidants; chromone; flavonoids; cytotoxicity; oxidative metabolism 
 
1. Introduction 
Oxidative/nitrosative stress is a phenomenon that is related to the formation of free radicals, 
reactive oxygen and nitrogen species (ROS/RNS) in excess. One of the major consequences of 
oxidative stress is the damage of biological macromolecules, including DNA, membrane lipids and 
proteins, leading to cell death. The uncontrolled oxidation of these molecules contributes to the 
development and/or progression of many diseases, such as ischemic heart disease, cancer, diabetes 
and stroke. 
In spite of the intensive research, the number of patients diagnosed with oxidative stress-related 
diseases is progressively increasing worldwide. Thus, the identification of novel countermeasures for 
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oxidative stress-induced pathologies is a major priority in both basic and clinical research, with 
particular emphasis on drug discovery efforts focused on natural compounds with antioxidant 
properties. Many plants contain so-called phytochemicals, which possess significant antioxidant 
properties. Indeed, epidemiological data clearly demonstrate that persons with phytochemical-rich 
diets experience significantly lower incidence of chronic illness as a direct result of such foods 
mitigating the effects of oxidative stress. It has been shown that grape seed proanthocyanidins have 
cardio-, reno- and hepato-protective effects [1–3]. Other examples include work by the authors of the 
present report, showing cardioprotective effects of sour cherry seed kernel extract on ischemia/ 
reperfusion-induced damage in isolated “working” diabetic and non-diabetic rat hearts [4,5]. 
Moreover, many laboratories worldwide have investigated the effects of Ginkgo biloba in different 
diseases [6–9]. Although, these examples show only a very narrow cross-section of the possible 
application of phytochemicals, there is a general agreement that the different natural antioxidant 
compounds, produced mainly by plants, exhibit huge promise as stand-alone or adjuvant agents in 
preventive medicine and therapy for diseases in which oxidative stress-induced tissue damage is a 
factor. Bioactive phytochemicals produced by plants prominently include phenoloids, terpenoids and 
alkaloids with antioxidant properties [10]. Among these, phenoloids are the largest group and comprise, 
among others, anthocyanins, coumarins (benzo-α-pyrones) and chromones (benzo-γ-pyrones). 
Flavonoids are the phenyl derivatives of chromones and possess well-known antioxidant activity. 
The antioxidant activity strongly depends on the substitution of the rings. The position and the type 
of the substituents are primary determinants of their biological properties [11]. 
The present investigation was conducted to evaluate the antioxidant properties and oxidative 
transformation of nine chromone derivatives (Table 1) selected from the molecule bank of the 
University of Debrecen. In our experiments, we determined the radical scavenging activity of the 
compounds using free radical scavenger assays. Furthermore, we measured the oxygen radical 
absorption capacity (ORAC) and the ferric reducing antioxidant power (FRAP) of the  
investigated compounds. 
Table 1. Compounds investigated in the study. 
 
ID Number R1 R2 R3 R4 
893 3,4-dihydro-2H-1,5-benzodioxepin-7-yl H H OH 
865 4-(dimethylamino)phenyl H H H 
987/3 3,4-dihydro-2H-1,5-benzodioxepin-7-yl H Me Me 
876 2H-1,3-benzodioxol-5-yl H H H 
1019/2 phenyl OAc H H 
890 phenyl H NAc H 
870 4-bromophenyl H H H 
991 4-methoxyphenyl H Me Me 
874 4-[(4-methylpiperazin-1-yl)carbonyl]phenyl H H H 
In additional studies, we determined the cytotoxicity on H9c2 cardiomyoblastoma cell cultures 
by the MTT assay and investigated the effects of the compounds against H2O2-induced cell death. 
Finally, following the selection of compounds according to their antioxidant properties, we 
investigated the oxidative transformation using biomimetic model systems including the Fenton 
reaction, artificial porphyrin and electrochemistry coupled to mass spectrometry (EC-MS) in order to 
obtain information about the metabolic stability. 
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2. Results 
In the first series of our experiments, we investigated the antioxidant properties of the compounds 
of interest. Results included negligible scavenging occurring in the case of galvinoxyl and DPPH 
radicals (data not shown), while compound Number 865, 4-N,N-dimethylamino-flavon (DMAF), 
exhibited significant scavenging activity against the ABTS radical (Figure 1). 
 
Figure 1. Free radical scavenger activity against the ABTS radical. All measurements were repeated 
three times. Data are expressed as the mean ± SEM. 
Furthermore, each compound has significantly higher oxygen radical absorption capacity (ORAC) 
compared to coumarin, which was here used as the reference standard (Figure 2). Moreover, DMAF 
had the highest ORAC value. 
 
Figure 2. Oxygen radical absorption capacity of the tested molecules. All measurements were carried 
out in duplicate and repeated four times for each investigated compounds. Data are expressed as the 
mean ± SEM. 
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Figure 3 shows the ferric reducing antioxidant power (FRAP) of the investigated chromone 
derivatives; and it was observed that some of the compounds (893, 987/3, 876 and 890) exhibited 
FRAP values similar to coumarin, while others, such as 1019/2, 870, 991 and 874, possess a slightly 
increased trolox equivalent. Moreover, in the case of DMAF, significantly increased FRAP activity 
was noted in comparison to the reference standard (coumarin) or the other compounds tested. 
 
Figure 3. Ferric reducing antioxidant power of the investigated chromone derivatives. All measurements 
were carried out in duplicate and repeated four times for each investigated compounds. Data are 
expressed as the mean ± SEM. 
The results of the MTT assay in Figure 4 reveal that none of the tested compounds mediated the 
cytotoxic effect (Figure 4, upper panel). Furthermore, six out of the nine molecules (893, 865, 987/3, 
876, 1019/2 and 890) significantly augmented H9c2 cell viability when the cells were treated with 125 
(Figure 4, middle panel) or 250 (Figure 4, lower panel) μM H2O2, respectively. 
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Figure 4. Cytotoxicity (upper panel) and the effects on H2O2-induced cell death (middle and lower 
panels) of the test compounds measured by MTT. Absorbance values were averaged across four 
replicate wells and repeated three times. Data are expressed as the mean ± SEM. 
Based on the beneficial properties of DMAF demonstrated by the antioxidant assays, this compound 
was investigated more closely towards its oxidative stability using biomimetic model systems. 
Initially, the oxidation of DMAF was performed by the chemical Fenton reaction followed by an  
off-line ESI-MS analysis (spectra not shown) in order to obtain information on the oxidation 
behaviour of the compound. By this means, three possible metabolites were detected with m/z 252.1, 
m/z 238.1 and m/z 282.1. Based on the peak intensities, the oxidation product with m/z 252.1 was formed 
with the highest yield, then 282.1, and with the lowest yield, the 238.1 oxidative product was obtained. 
In additional experiments, we investigated the oxidative transformation of DMAF by the application 
of Fe(III) meso-tetra (4-sulfonatophenyl) porphine chloride. The metabolites were detected by HPLC-
MS/MS (spectra not shown). Based on the analysis of the measured spectra, the oxidation products 
with m/z 238.1 and m/z 282.1 were also detected. Furthermore, other possible metabolic products with 
m/z 280.1 and m/z 265.5 were also detected. The oxidation product with m/z 252.1 was additionally 
detected; however, it was also present in the control sample with the same retention time as in the 
sample and is thus most likely an impurity of DMAF. In this case, the major product was found to be 
m/z 280.1. 
Finally, the oxidation of DMAF was carried out using an electrochemical cell coupled to mass 
spectrometry. Therefore, a potential ramp was applied to the EC cell while mass spectra where recorded 
continuously. Plotting the mass spectra in dependence of the applied potential, a so-called mass 
voltammogram was obtained (Figure 5). The oxidation of DMAF (m/z 266.1165) can be identified by 
the decreasing signal intensity at increasing potentials starting at around 1500 mV. Moreover, m/z 
252.1014 was detected already without potential application, which most likely can be attributed to 
an ion source oxidation. Nonetheless, the signal intensity of m/z 252.1014 increases at higher 
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potentials representing the electrochemical oxidation, but afterwards also decreases, indicating a 
further oxidation of this product. With similarity to the Fenton system, the major oxidation product 
was found to be m/z 252.1014, while the product with m/z 280.0959, which was also produced by the 
artificial porphyrin, was generated with the second highest yield. Using EC-MS, the other metabolites 
with m/z 238.0858 and m/z 282.1113 could also be detected (Figure 5, insert panels). 
 
Figure 5. Electrochemical oxidation of 4-N,N-dimethylamino-flavon (DMAF) by potential ramp 
application of 0–2500 mV. 
3. Discussion 
Phytochemicals are compounds occurring at high concentrations mainly in vegetables, fruits 
and their seeds and legumes. These are not essential micronutrients, but possess significant  
health-promoting properties. The main classes of these are alkaloids, terpenoids and phenoloids. 
Among phenolids, many molecules have a chromone (4H-benzopyran-4-one) or a coumarin (2H-
benzopyran-2-one) basic skeleton. Both compound types possess a wide range of biological properties, 
including antioxidant, anti-inflammatory, antimicrobial, antiallergenic, anti-ischemic, antiviral, anti-
hypertensive and antitumor activities [12,13]. Because the isolation and purification is not efficient 
and generally results in low yield of the bioactive compounds, many laboratories worldwide make 
an effort in the synthesis or semisynthetic modification of different compounds with natural origin 
in order to obtain derivatives with enhanced biological activities and prepare these at large scale, 
which is suitable to carry out in-depth pharmacological studies in vitro and in vivo. Certain 
phytochemical classes have molecular structural features that make them particularly suitable for the 
creation of derivatives with novel properties. For example, the coumarin and chromone scaffolds are 
promising ring systems for the design and synthesis of new molecules with different biological  
effects [14–19]. In this study, we made attempts to investigate the in vitro antioxidant activity and 
oxidative transformation of nine different chromone derivatives. For the characterization of the 
antioxidant properties, either electron transfer (ET)- or hydrogen atom transfer (HAT)-based assays were 
chosen as the main investigative tools. In the case of the HAT-based assay (ORAC), each compound 
showed significant activity, with DMAF (865) manifesting a significantly higher ORAC value in 
comparison with phytochemicals based on other flavonoid structures. Surprisingly, the results of the 
ET-based assays revealed that DMAF, which is a simple flavonoid derivative, has the most robust 
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FRAP and radical scavenger activity against the ABTS radical. It is thus noteworthy that in different 
studies when ET-based (ABTS, DPPH, FRAP) assays were used to compare antioxidant activity,  
the results were similar, while for those in which the ORAC test was used, the results were different. 
It is also important to note that on the basis of a single test, a compound cannot be definitively 
classified as an antioxidant; hence, a series of tests to make this determination is typically necessary. 
Another factor to consider is that the values of the assays used to determine the antioxidant activity 
of a particular compound may vary from study to study despite testing standardization by 
investigators. This problem poses challenges in the unified interpretation of assay outcomes for new 
compounds in the context of earlier reported data. Based on our results, DMAF exhibited significant 
antioxidant activity in each assay with no significant cytotoxicity. Moreover, DMAF also prevented 
H2O2-induced cell death, a property that underscored its potential for future studies of its metabolic 
stability and possible benefits to human and veterinary health. 
The above-mentioned factors notwithstanding, the positive outcomes of the assessment of the 
antioxidant effects under in vitro conditions are not typically considered to be an independently 
sufficient cause for the allocation of time and resources for a particular phytochemical compound as 
a candidate for the further stages of the drug R&D process. Other properties of the molecule of 
interest must be considered, such as the stability and toxicity of the compound. One of the most 
important factors that determines the toxicity and pharmacologic effects of a drug candidate is its 
oxidative metabolism. Therefore, it is very important to investigate the metabolic stability of the 
investigated compounds. The so-called biomimetic systems may be used as an essential component 
of preclinical studies to select the most suitable drug candidates for later extended pharmacokinetic 
and toxicological animal tests and eventually for clinical (phases I–III) studies. Oxidation can be 
performed either by the Fenton reaction, systems containing synthetic porphyrins or by the 
application of electrochemistry using either off-line or on-line mass spectrometric detection [20]. The 
Fenton system was shown to be capable of stimulating N-dealkylation, S-oxidation and the 
hydroxylation reaction; metalloporphyrins are most suitable to mimic S-oxidation, N-dealkylation, 
N-oxide formation, epoxidation, hydroxylation and dehydrogenation, while EC-triggered systems are 
suitable for modelling N-dealkylation, S-, P-oxidation, aromatic hydroxylation and dehydrogenation 
reactions [21]. By use of each of these three assays in the present study, four possible metabolites of 
DMAF were detected. The corresponding proposed reaction scheme is illustrated in Figure 6. 
 
Figure 6. Proposed metabolic transformation of DMAF. 
First, N-dealkylation of a tertiary amine to a secondary amine (m/z 252.1019) was obtained, followed 
by the removal of a further methyl group, resulting in a primer amine (m/z 238.0863). These products 
were detected by means of all three model systems (Table 2) since each technique is suitable for 
mimicking N-dealkylation reactions. Additionally, the formation of the product with m/z 282.1125 
presumably resulted from processes that include aromatic hydroxylation on the B ring, a conclusion 
that was deduced from the observed fragmentation pattern of this molecule (data not shown).  
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The following dehydrogenation leading to m/z 280.0968 though a (possible) cyclization between the 
C3 and C6′ is proposed. Because the applied methods constitute a good model system for hydroxylation, 
it is not surprising that this product was detected in each case. The dehydrogenated form was not 
detected by the Fenton reaction, possibly because of the low concentration of this product, which may 
have been at levels below the limit of detection. 
Table 2. Detected possible metabolites of DMAF. 
Product Fenton System EC System Porphyrin System 
865 − CH3 + + − * 
865 − 2CH3 + + + 
865 + O + + + 
865 + O − 2H − + + 
* It was detected, however considered as an impurity. 
4. Materials and Methods 
4.1. Chemicals 
Water (ultra-pure) was prepared with the SolPure 78 water purification system from Poll Lab 
(Bielsko-Biala, Poland). Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA-Na2),  
L(+)-ascorbic acid, ethanol (96%), acetic acid and formic acid were obtained from Scharlab 
Magyarország Kft. (Debrecen, Hungary). Iron(III) chloride, hydrogen peroxide solution, potassium 
hydrogen phosphate, monopotassium phosphate, sodium citrate, citric acid, 2,2′-azobis (2-
amidinopropane) dihydrochloride (AAPH), sodium acetate trihydrate, 2,4,6-Tris(2-pyridyl)-s-
triazine (TPTZ), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS-salt), 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), isopropanol and fluorescein 
were obtained from Sigma-Aldrich Kft. (Budapest, Hungary). Fe(III) meso-tetra(4-sulfonatophenyl) 
porphine chloride was obtained from Frontier Scientific (Logan, UT, USA). Ammonium formate 
(≥99.995%, trace metal basis) was ordered from Sigma-Aldrich (Steinheim, Germany). Acetonitrile 
(LC-MS grade) was delivered from Merck (Darmstadt, Germany). 
Test compounds were selected from the molecule bank of the University of Debrecen. This 
compound “library” contains nearly 3000 compounds available for investigative use at high purity 
(>95%), including a large number of oxygen-containing heterocyclic compounds along with their 
precursors. Among these compounds, 175 bear the flavonoid moiety. Test compounds were 
randomly selected from this subset for possible use in the present investigation. A major criterion in 
this selection process, was novelty; specifically, phytochemicals were chosen that had never been 
previously subjected to the kind of analyses conducted in the experiments described in the present 
report. Another major strategy in this selection process is that the range of compounds chosen 
represented the greatest extent of the entire substitution pattern for the flavonoid ring within the 
constraint of the choices offered by this small library. 
4.2. ABTS Assay 
The ABTS solution was prepared by dissolving ABTS-salt (2,2′-azino-bis(3-ethylbenzothiazoline- 
6-sulfonic acid) diammonium salt) in citric acid-sodium citrate buffer (pH 6, 50 mM) containing 2% 
ethanol (96%). ABTS+ (100 μM) was generated with the ABTS/H2O2/metmyoglobin system and mixed 
with the investigated compounds (25 μM). The reaction was carried out for 2 h at room temperature. 
During this period, the absorbance of ABTS+ was monitored at 730 nm with a Helios-α-spectrophotometer 
at 0, 5, 15, 30, 60, 90, 120 min. All measurements were repeated three times. Data are expressed as the 
mean ± SEM. The results can be seen in Figure 1. 
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4.3. ORAC Assay 
The ORAC assay was carried out as described by Glazer et al. [22], with modification.  
Freshly-prepared AAPH stock (37.5 mM) solution and fluorescein stock solution (0.6 μM) in 
phosphate buffer 75 mM, (pH 7.0) were used for the assay. The concentration of the investigated 
compounds was 0.05 mg/mL. For all experiments, the final reaction volume of the wells was 200 μL, 
containing 65 μL of buffer, 20 μL of fluorescein, 15 μL of compounds of interest, except the blank and 
the reactions were initiated by an addition 100 μL of AAPH stock solution. Black-sided micro plates 
were incubated at 37 °C. The fluorescence (excitation wavelength of 485 nm and emission wavelength 
of 520 nm) was monitored every 2 min for 1 h by the FLUOstar OPTIMA (BMG LABTECH) plate 
reader. The area under the curve (AUC) was calculated as the following: 
AUC= 0.5 + (R2/R1) + (R3/R1) + (R4/R1) + …. + (Rn/R1) (1) 
where R1 is the initial fluorescence reading at 0 min and Rn is the fluorescence reading at n min. 
Finally, the net AUC was obtained by subtracting the AUC of the blank from that of a sample. 
AUCnet = AUC sample − AUC blank (2) 
All measurements were carried out in duplicate and repeated four times for each tested compound. 
Data are expressed as the mean ± SEM. Results are shown in Figure 2. 
4.4. FRAP Assay 
The ferric reducing ability of the investigated compounds was determined by the FRAP assay. 
The prepared stock solutions for the assay contained acetate buffer solution (pH 3.6, 300 mM), TPTZ 
solution (10 mM) in 40 mM HCl and ferric chloride (FeCl3) solution (20 mM). The freshly-prepared 
working solution contained 25 mL of acetate buffer and 2.5–2.5 mL of TPTZ and ferric chloride 
solution, and the FRAP reagent was activated by incubation on 37 °C for 15 min. The reaction mixture 
consisted of 950 μL FRAP working solution and 50 μL of the investigated compound (0.05 mg/mL), 
except the blank sample. After 15 min of incubation at 37 °C, the absorbance of the coloured product 
was measured at 593 nm with a Helios-α-spectrophotometer. The FRAP values were expressed as 
trolox equivalents (μM/mL), based on the trolox standard calibration curve prepared by measuring 
of the different concentrations of trolox samples (0.015, 0.045, 0.105 and 0.21 mM). All measurements 
were carried out in duplicate and repeated four times for each investigated compounds. Data are 
expressed as the mean ± SEM. Results can be found in Figure 3. 
4.5. Measurement of Cytotoxicity 
Evaluation of the cytotoxicity of the investigated compounds on cellular survival was accomplished 
using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, H9c2 
cells (ATCC, CRL-1446, LGC Standards GmbH, Wesel, Germany) dissociated by trituration in 
medium (Dulbecco’s modified eagle’s medium from Sigma with 10% FBS, 1% penicillin-streptomycin) 
were seeded into 96-well plates at a density of 3000 cells/well and cultured for 1 day to establish 
adhesion of the wells. Next day cells were treated with 150 μM antioxidant containing medium. 
Following a 30-min incubation period, the wells were treated with 0, 125 or 250 μM H2O2. Four hours 
later, the addition of 20 μL MTT solution (5 mg/mL in PBS) to each well and an additional 3 h 
incubation at 37 °C to allow mitochondrial uptake was performed. Finally, the medium was removed, 
and cells were lysed by the addition of 150 μL of isopropanol, incubated for 15 min followed by the 
measurement of absorbance at 570 and 690 nm using a plate reader (FLUOstar OPTIMA, BMG 
Labtech). Within each experiment, the absorbance values were averaged across 4 replicate wells and 
repeated 3 times. The cytotoxic effect assessments were estimated based on the linear correlation of 
the absorbance values with MTT-associated H9c2 viability and reported as the percentage of cells 
surviving 4 h of investigated antioxidant exposure relative to control cells not exposed to compounds. 
Data are expressed as the mean ± SEM. The results can be seen in Figure 4. 
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4.6. The Chemical Fenton System 
The chemical Fenton system was prepared based on a method reported previously by  
Jurva et al. [23] The reaction mixture consisted of 400 μL 2.5 mM 865 in acetonitrile, 50 μL 20 mM 
FeCl3 and 50 μL 20 mM EDTA-Na2 in acetonitrile/water (50:50), 500 μL 10 mM ascorbic acid in 
acetonitrile/water (50:50) and 1 μL 30% hydrogen peroxide. The control sample in the absence of 
hydrogen peroxide and the blank sample without the test compound were prepared. The mixtures 
were stirred at room temperature at 600 rpm. Samples were drawn at 30 min, 140 min, 18 h and  
261 h and were analysed immediately by an API 2000 Triple Quadrupole mass spectrometer (Applied 
Biosystems, Waltham, MA, USA) equipped with a syringe pump. The flow rate was set to  
100 μL/min, curtain gas 10 PSI, declustering potential 20 V, ion spray voltage 4000 V, focusing 
potential 400 V, ion source temperature 200 °C. ESI mass spectra were recorded in the range  
of m/z 100–500 in positive-ion mode with Analyst 1.5.1. Software (AB SCIEX, Concord, ON, Canada). 
4.7. Oxidation by Artificial Porphyrin 
The porphyrin system was prepared based on a method reported previously by Johansson et al. [21]. 
The reaction mixture consisted of 50 μL 10 mM 865 in acetonitrile, 35 μL acetonitrile, 315 μL 100 mM 
formic acid, 50 μL 10 mM Fe(III) meso-tetra(4-sulfonatophenyl)porphine chloride and 50 μL 30% 
H2O2. The control sample in the absence of hydrogen peroxide and the blank sample without the test 
compound were prepared. The mixtures were shaken at 37 °C for 30 min at 700 rpm in a shaking 
water bath. One hundred microlitres of the reaction mixture were diluted to 2 mL with acetonitrile/ 
water (50:50). After HPLC separation (column: Kinetex XB-C18 2.6 μm, eluent: 0.1% formic acid in 
water and acetonitrile with 0.1% formic acid, gradient elution), the samples were introduced into an 
LTQ XL linear ion trap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) under the 
following conditions: sheath gas flow rate 35.00 a.u., spray voltage 5000 V, capillary temperature  
300 °C, capillary voltage 31 V, tube lens voltage 150 V, skimmer voltage 34 V. 
4.8. Electrochemical Oxidation 
N,N-Dimethylaminoflavone (DMAF) was oxidized using an electrochemical thin-layer cell 
(FlexCell, Antec, Zoeterwoude, The Netherlands). The cell was equipped with a boron-doped 
diamond (BDD) working electrode, a graphite doped Teflon counter electrode and a Pd/H2 reference 
electrode. A potential ramp from 0–2500 mV with a scan rate of 10 mV/s was applied using a 
homemade potentiostat. DMAF in ammonium-formate (10 mM, pH 7.4) and acetonitrile 50/50 (v/v) 
was continuously pumped through the cell with a flow-rate of 10 μL/min delivered by a syringe 
pump (Model 74900, Cole Parmer, Vernon Hills, IL, USA). The effluent of the cell was introduced 
into an Exactive mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). The full scan 
spectra (m/z 100–800) were recorded in ESI(+) mode under the following conditions: sheath gas flow 
rate 10.00 a.u., spray voltage 4000 V, capillary temperature 250 °C, capillary voltage 42.5 V, tube lens 
voltage 135 V, skimmer voltage 34 V. The software XCalibur 2.1 (Thermo Fisher Scientific, Bremen, 
Germany) was applied for data processing, and data visualization was performed by plotting the 
recorded mass spectra in dependence of the applied potential in the form of a three-dimensional mass 
voltammogram using the software Origin 9.1 (OriginLab, Northhampton, MA, USA). Results are 
shown in Figure 5. 
5. Conclusions 
The major value of the present study is in offering a full characterization of the phytochemical 
antioxidant ability for potential use in health maintenance provided by the data shown; and also, the 
strategy for producing this. A particularly significant result in this context is the observation that  
4-N,N-dimethyl-flavone exhibited significant antioxidant activity and was metabolically stable. This 
outcome thus justifies its use as a research tool in the investigation of its effects in selected animal 
models of oxidative stress-related disease. Ongoing characterization of these processes is continuing 
by this laboratory. Furthermore, each compound evaluated here demonstrated significant ORAC 
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activity, along with supporting evidence of their antioxidant capacities as assessed and further 
characterization by TRAP, CUPRAC, SOD and catalase activity, and the effects on the mitochondrial e− 
transport chain, by our laboratory and other investigators, demonstrate significant potential for 
return-on-investment (ROI) in the design of novel strategies for human and animal use for 
phytochemical antioxidants. 
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